On 23rd March, the Government demanded that the majority of public-facing businesses close their doors. Veterinary surgeries, however, have been exempted and are allowed to remain open.
However, the number of clients seen face-to-face should be kept to an absolute minimum and veterinary teams must insist on strict social distancing measures at all times.
In addition, the RCVS/BVA say that:
The College has updated its FAQs for veterinary professionals, which can be found here: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The BVA is now developing some further guidance to provide examples of what constitutes routine, urgent and emergency care.
If, as is predicted, social distancing methods need to be employed to reduce the spread of the virus, or clients find themselves having to self-isolate, video consultations may offer a way in which veterinary practices can continue to serve their clients, maintain animal welfare and, importantly, revenue.
VetHelpDirect's video consultation system, which was announced earlier this year, is still in the Beta testing phase, and the plan had been to roll out the full service in May.
Under the circumstances, however, the company has decided to offer the service to all practices immediately, free of charge for the next three months.
To use the video consultation service, you do need to subscribe to use VetHelpDirect, a service through which you can manage client reviews of your practice. That costs £38 per month, per practice and a further £16 for branch practices.
Susie Samuel, CEO of VetHelpDirect said: “The Coronavirus presents a very real business risk to veterinary practices and a health risk to staff.
"As cases increase, animal owners in quarantine will not be able to visit the vet when their animals become unwell. In these cases, veterinary practitioners will not be able to discuss an animal’s symptoms with their owner in person and could end up relying solely on telephone consultations which would most likely be conducted free of charge.
"Our video platform allows vets to collect payment for a consultation as usual, hold the consultation with the animal’s owner and if a pet needs to be seen, the owner could, in theory, drop it off at the surgery without making personal contact with the vet clinic staff."
VetHelpDirect has not yet decided precisely what the video consultation service will cost after the free period, but it is likely to be around the £20 per month mark. In addition, there is a 4.8% transaction fee.
For more information, contact Susie Samuel susie@vethelpdirect.com
COMMENTDespite the emergence of a number of online-only, limited-service veterinary video consultation providers, it seems like very few, if any independent practices are yet offering this service. There is a danger that unless they do so very soon, they will find themselves at a real disadvantage to the first movers. But there is still time; according to VetHelpDirect's research, 38% of people say they would use video consultations with their own vet but only 7% with a vet they don't know..
It strikes me that now is a very good moment to start offering clients this kind of service, because regardless of government advice, there will doubtless be some who will want to avoid a trip to the vets whilst the outbreak persists.
Bovilis Nasalgen-C can be used for the active immunisation of calves from the day of birth onwards to reduce clinical signs of upper respiratory tract disease and nasal viral shedding from infection with BCoV.
MSD says respiratory disease in UK calves is widespread and comes at a high cost from an emotional and business productivity perspective.
It is also continually highlighted as a critical area for overuse of antibiotics.
Despite all this, there is an under use of vaccination in the UK cattle sector1.
Speaking at BCVA last week, Paul Burr MRCVS, director of Biobest Laboratories said: “Recent UK studies show bovine coronavirus being the most prevalent virus found in routine disease screening and nasal swab samples taken during a bovine respiratory disease outbreak.
"BCoV was found in 39% of over 400 nasal swab samples taken between 2020 and 2022 from BRD affected cattle on UK farms2.”
Kat Baxter-Smith, veterinary adviser with MSD Animal Health, said: “Whilst the pathogenicity of BCoV within the BRD complex remains an unknown quantity, its ubiquitous presence in the UK cattle population – and the recent human experience of coronavirus as a significant respiratory pathogen – suggests a need for a re-evaluation of BRD control by vets and farmers.
“Just as coronavirus is a pathogen associated with the common cold and Covid-19, BCoV is a proven pathogen that directly impacts the calf respiratory tract.
"Consequently, the availability of this new BRD vaccine presents veterinary professionals with another tool in their armoury to improve control of this costly disease.
“If diagnostics suggest BCoV is implicated in any BRD problem, the availability of Bovilis Nasalgen-C allows UK cattle farmers to effectively administer protection for young calves via a single 2ml intranasal dose that can quickly reach the site of action.
"This will support the development of immunity against BCoV early in life, the onset of which starts five days after administration and has a 12-week duration.”
Bovilis Nasalgen-C comes can be used on the same day with Bovilis INtranasal RSPÔ Live, which offers protection against both Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3).
Bovilis Nasalgen-C can be stored for up to 24 hours at room temperature after reconstitution, can be given to cattle using a syringe or applicator device and is available in one, five and 20 dose packs, suitable for both small and large herds.
References:
Mr Roger faced three charges: that he had failed to provide adequate care, failed to communicate with the owner adequately and failed to keep adequate clinical records for Honey, a Shiih Tzu dog who, it transpired, had hypergycaemia.
At the initial consultation, Mr Roger took a blood sample which showed that there was an elevated blood glucose, an elevated white blood cell count, an elevated ALT and an elevated ALP (which Mr Roger took to be indicative of liver damage secondary to infection).
Mr Roger prescribed a cholagogue (ursodeoxycholic acid), an antibiotic (Synulox) and a diuretic (Frusemide).
In its findings of fact, the Committee found it likely that Mr Roger would have realised that Honey had a potential diabetes mellitus diagnosis with an elevated blood glucose of 28.
However, Mr Roger explained that he had believed the elevated blood glucose was due to the stress Honey had undergone in taking the blood samples.
The Committee therefore accepted that Mr Roger’s actions did not indicate a complete failure by him to notice the elevated blood glucose because he had explained he believed at the time it was due to stress.
Honey’s owner took her back to the veterinary practice that Mr Roger worked at three days later.
A different veterinary surgeon examined Honey and flagged that her blood sugar was high and that her liver was damaged.
She was taken to an alternative veterinary practice for follow-up but died later that day.
Mr Roger admitted failing to ask Honey’s owner if there was a history of diabetes mellitus, failing to take repeat blood glucose tests or carry out urine analysis or carry out additional blood tests, failing to communicate adequately with Honey’s owner about the significance of the hyperglycaemia and the options for investigation/management and failing to keep adequate clinical records in regard to Honey’s blood glucose levels.
The Committee found the admitted facts proved.
The evidence presented to the Committee included the clinical notes taken during Honey’s consultations, emails sent from Honey’s owner to the RCVS outlining the complaint, and evidence from experts in small animal veterinary practice.
Although the Committee found some matters not proved, it did find proved that Mr Roger had failed to recognise and/or pay adequate regard to Honey’s elevated blood glucose levels, had failed to manage Honey’s hyperglycaemia either by treating it or by documenting an appropriate plan to do so and had failed to communicate adequately with Honey’s owner about the significance of her elevated glucose and the reason for it.
Having reached its decision in relation to the facts, the Committee went on to consider whether the facts it had found proved either individually or cumulatively amounted to serious professional misconduct.
Judith Way, Chairing the Committee and speaking on its behalf said: “The Committee found that the charges and particulars it had found proved did not amount to disgraceful conduct in a professional respect either individually or cumulatively.
"In its judgment, the conduct found proved fell short of the standard to be expected of a reasonably competent veterinary surgeon but not far short of the standard which is expected of the reasonably competent veterinary surgeon.”
As a result of the Committee finding that Mr Roger was not guilty of serious professional misconduct on any of the proven charges, either individually or in any combination, the hearing did not proceed further.
The authors say that study seeks to redress the lack of evidence-based information that has so far been published on the epidemiology and clinical management of non-neoplastic anal sac disorders (ASD).
The study, which was carried out within the RVC’s VetCompass programme, focused especially on identifying breeds with increased or reduced risk of anal sac disorders.
The breeds at greatest risk of an anal sac disorder compared with crossbreeds included Cavalier King Charles spaniel, King Charles spaniel and Cockapoo.
Conversely, breeds at reduced risk included larger breed dogs including Boxer, German Shepherd Dog and Lurcher. Flat-faced (brachycephalic) breeds such as Shih Tzu had 2.6 times the risk for anal sac disorders compared to long-skulled breeds such as Border Collies. Spaniel-types, Dachshund-types and Poodle also showed increased risk for anal sac disease.
The study identified 2,372 anal sac disorder cases from a population of 104,212 dogs attending VetCompass participating practices during 2013.
Other findings included:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: “During two decades in first opinion practice, anal sac problems in dogs were a routine daily presentation for me. However, when I searched the literature to find evidence on the best way to treat these dogs or even on which breeds were at most risk, there was almost no information available. It seemed back then that only problems that were severe enough to be referred to universities in large numbers were researched.
"As a result, vets in first opinion practice generally had to work out for themselves what seemed to be the best treatment in these cases. It is refreshing now to see research on common problems in dogs under first opinion veterinary care being reported. Owners and vets needs this evidence vitally.”
Anette Loeffler, Associate Professor of Veterinary Dermatology at the RVC and co-author of the paper, said: "This study shines a spotlight on critically important area of veterinary practice: antibiotic usage. Twenty percent of dogs presenting with an anal sac disorder received antibiotics even though diagnostic criteria for anal sac infection or proof of efficacy of antibiotic treatment are lacking.
"At a time when antimicrobial resistance presents one of the biggest threats to human and animal health, this highlights an urgent need for further study of these disorders in order to improve dog welfare but also to help vets in making responsible antibiotic treatment decisions in the interest of public health.”
The Apple iPad made its UK debut last week. I queued outside the Apple shop for over 15 minutes (well, it was Salisbury, not Regent Street) on launch day to get my hands on one of the first and review it for VetSurgeon members.
For those that don't have the time for long-winded reviews, I'll come straight to the point: buy one, you won't regret it. Even if you get home and decide you have no use for a tablet computer, you could probably put it on ebay and turn a small profit. But you won't. You'll just keep finding more reasons why the iPad is an indispensable piece of kit.
I won't dwell on the technical specifications of the thing. All you really need to know is that it's a touchscreen tablet computer about the size of a small hardback, though it weighs a little more. I don't know (or care) what sort of chip it contains. Whatever it is, it's more than capable of handling the tasks the iPad is designed to do, effortlessly.
So why is the iPad a 'must have'? Because it transforms the experience of browsing the Internet, reading email etc. from being a bit of a hassle, to being as simple and quick as, er, picking up and opening a book. I think the best way to illustrate my point is to describe the uses I've found for it in the first 4 days of ownership:
BrowsingI wanted to know what's on locally for children this weekend. Normally I'd have to go and power up the computer upstairs. Not anymore. Now I just pick the iPad up off the kitchen table. It wakes instantaneously, and the browser opens at the press of a button. Incidentally, once I'd found the Sherborne Fair, it was only another couple of clicks before it was displayed on the built-in map, along with an estimated time to get there. In my case, it also makes my job easier - I can dip into the VetSurgeon and VetNurse forums much more easily when away from my desk (something I intend to be more of, from now on).
EmailNot much to say, except that once again, it's a pleasure to be able to check my email at the press of a button, rather than having to go upstairs and power up my desktop, or wait whilst my wife's interminably slow laptop gets its act together. No, the touch screen keyboard is not quite as well suited to the task as a normal keyboard. Having said that, I typed half this article on my iPad last night at very nearly the same two-handed speed as I would have on my desktop.
Read the newspaperThe Times is now available on the iPad for £9.99 per month. You just press the download button any time after 7:00am, and a few minutes later it appears on the screen. If you fall into the camp that says: 'it'll-never-catch-on-....-nothing'll-replace-the-feel-of-a-book-or-a-newspaper', I wouldn't have argued with you a week ago. Now I would. The iPad version is beautifully intuitive, and a pleasure to read. Despite a few grumbles (where is The Sunday Times?), I'll be cancelling my print subscription.
PhotographsThis is really the first viable alternative to the traditional print photograph album. And it's not just an alternative, it's a far superior way of storing and retrieving photographs. The iPad's high quality display means your pictures really leap off the screen. Its portability and ease of access mean that you might actually look at your photos and share them with others from time-to-time, rather than leaving them to gather dust in a box, or sit in an unvisited folder on your computer. I'm digitising 20 year's worth of photographs for this reason.
Other uses and appsThe list of software applications for the iPad is growing every day. Meantime, any app designed for the iPhone will also run on the iPad, though they don't make full use of the big screen. There are thousands of rather pointless apps, seemingly designed not to meet a need nobody knew they had. But amongst the rubbish, there are some genuinely useful apps out there:
A couple of minor irritations about the iPad. Currently it doesn't support the rich editing feature used by default when you post to the VetSurgeon forums, or elsewhere on the site. Fortunately, there's a quick workaround, which is to visit your VetSurgeon profile (My Account > Edit My Profile > Display Options tab) and set the Content Editor to 'Plain text'. Also, very occasionally the iPad freezes, at which point you have to press the On/Off and Home buttons together for six seconds to reset. Doubtless both these will be fixed in the next software update, due in the next month or two, I think.
The 'twitterati' has bemoaned the iPad's lack of hardware features and flexibility. There's nowhere to insert a DVD. No camera. No USB port. No card reader. But that rather misses the point. The iPad isn't a replacement for a desktop or laptop unless the only things you use a computer for are browsing and email. Anyone who wants to store and edit video, edit photographs, or create anything other than fairly basic documents or spreadsheets, still needs a bigger machine with USB ports and DVD drives galore. What the iPad does is free you from having to browse electronic media at a desk. And it does so in such user-friendly way that I'll be ordering one for my Mum (aged 62) and my grandmother (aged 92).
There are six models available. Three memory sizes: 16GB, 32GB and 64GB with either wi-fi Internet access, or wi-fi plus 3G mobile phone access. Prices from £429 to about £700 (to which you'll need to add the cost of a protective wallet). I plumped for the 64GB memory (probably overkill), wi-fi only model, on the basis that there are enough BT Openzone wi-fi hotspots now to mean I'll never be far from one.
I'm not normally one for hyperbole. But in this case, I'll forgive Mr. Jobs calling the iPad 'a magical and revolutionary product'.
It is.
Salmoporc gives protection against Salmonella Typhimurium and its monophasic variants. It is administered orally to piglets and through subcutaneous injection in sows.
According to the company, Salmoporc is the only live, attenuated salmonella vaccine licensed for pigs in the UK and Ireland.
Ceva says salmonella in UK and Irish herds is the highest in the EU, with a prevalence of 19.5% and 17.5% respectively. It is particularly difficult to control in outdoor herds since the bacteria can survive in soil for a year, even longer in dried dung and has been detected in fields two years after being vacated by pigs.
Outdoor bred, or reared, pigmeat accounts for 12% of retail sales and the majority of this is processed.
Dr Rike Schmelz from Ceva said: "Salmonella is an increasing problem on pig farms and the bacteria are transmitted through breeding pyramids which eventually supply finishing pigs. Clinical cases of diarrhoea often occur after weaning and tend to be treated with antibiotics."
Rike added: "The monophasic variant of S. Typhimurium is already multi-drug resistant and vaccinating pigs can help farmers to substantially reduce their use of expensive antibiotics. In addition, with the removal of zinc oxide at therapeutic levels from the feed in mid-2022, salmonella and other enteric diseases are likely to become more apparent."
Ceva says that by immunising their pigs against S. Typhimurium, farmers will gain an economic benefit from lowered mortality and improved daily liveweight gain (DLWG) among their pigs.
In independent trials at the University of Ghent in Belgium, between three and 29 weeks, vaccinated piglets from three herds gained between 30g and 39g, significantly more per day than unvaccinated controls.
Trials in Germany have shown that, with vaccination of sows and gilts at the top of the breeding pyramid, combined with a competent hygiene programme, it is possible to eliminate salmonella from the supply chain.
The website has been redesigned to help pet owners improve their understanding of the disease and support their commitment to treating their pet, thus improving the survival rates of diabetic pets.
The site includes videos which show how to give insulin injections to dogs and cats. There are also links to the Pet Diabetes Tracker App, which helps owners of diabetic pets monitor and record their pets’ progress. There are also tools to help pet owners build glucose curves they can share with their veterinary practice, and FAQs that will answer their main concerns.
The company is also offering additional support to help veterinary practices raise awareness of pet diabetes in the form of staff training and a Pet Diabetes Month Resource Pack.
Caroline Darouj, Senior Product Manager at MSD Animal Health said: "Pet diabetes continues to rise in the UK1,2 due to the growing prevalance of obesity in our pets. Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis3. Many of these early deaths however, are avoidable and effective management can result in good outcomes in most pets. A diabetes diagnosis should not be a life sentence for our pets.
"This campaign and new website will make a big difference, giving practices the tools to engage pet owners, provide treatments plans and explain effective disease management. Diabetes is a disease with many elements that can feel overwhelming for pet owners so it’s vital that all veterinary practice team members have the right resources to be able to advise and support them so their pets can lead long and happy lives."
To sign up for a pack practices should go to www.msd-animal-health-hub.co.uk/PDM
References
The flowchart, which was produced in partnership with the National Animal Health and Welfare Panel (NAHWP) and with support from Dogs Trust, outlines what vets should consider when a client presents an animal with a pet passport and aim to help them navigate client confidentiality, how to report concerns of illegal imports, and an overview of how local authorities are likely to respond.
The Association says that in recent years, vets have mentioned finding it 'difficult' or 'very difficult' to report concerns to Trading Standards in the BVA Voice of the Veterinary Profession surveys. Other concerns included breaching client confidentiality, a lack of proof or sufficient evidence to investigate, a perceived lack of interest from local authorities if a case was reported, and uncertainty about whom to contact and how to report suspicions.
Findings released by Dogs Trust earlier this week show broadly similar concerns about reporting suspected illegal pet import cases.
BVA and NAHWP have issued the following advice for vets:
Report any suspicions that the animal in your care does not comply with Pet Travel Scheme requirements to your Local Authority Animal Health Function – either Trading Standards or Environmental Health Services.
Find out how to contact your local authority via a pre-agreed number for your practice. Find a direct contact number for your local Trading Standards or call Citizens Advice Consumer Helpline on 03454 04 05 06, who will refer you directly to the relevant local authority.
Note this number down on the joint BVA and NAHWP compliance flowchart and put up the poster in visible locations around your practice for staff to refer to.
BVA is also in talks with local authority forums in Wales and Scotland and the Department of Agriculture, Environment and Rural Affairs in Northern Ireland to launch similar guidance and compliance resources for vets in the devolved administrations.
BVA President Daniella Dos Santos said: "Veterinary teams can often be the first to suspect that an animal may have been illegally imported when an owner takes their pet for its first check-up. But our surveys have identified a compelling need for clearly defined routes and mechanisms for vets to more easily report suspected cases of illegal import.
"Our flow chart and supporting guidance aim to empower vets to report any such cases, thus helping to tackle the scourge of illegal importation and protecting animal welfare, both of the imported dogs and the larger canine population in the UK.
"I would encourage veterinary teams to put up the poster in their practices and use it to help report any suspicions to relevant authorities with ease."
The flowchart is available as a pull-out poster in this week’s Vet Record and can also be downloaded along with accompanying guidance notes here: www.bva.co.uk/illegalimportguidance
The survey, which received over 1300 responses, found that the problem is more noticeable amongst locum vets (69% have worked when they’ve not felt well enough) and employees (64%) but is also an issue amongst partners and the self-employed (57%). It’s more common for vets in clinical practice (65%) than in non-clinical roles (51%). In all of these sectors over half of vets reported working when they were unwell.
18% of the vets surveyed said they do not take sick leave because they feel uncomfortable doing so. This is more common amongst younger vets (25% of under 35s compared to 19% of 35-54-year olds, and 8% of over 55s) and female vets (21% compared to 11% of male vets).
The main reasons given for not taking time off when sick are concerns about the impact on colleagues and worries about "letting the team down". One respondent said: "Because I would leave the practice understaffed and the remaining vets would have to work a lot harder and longer as a result." Another said: "Being ill is not an option. The practice is short staffed."
Members also reported a perceived culture of working through sickness. One said: "The veterinary industry on the whole has a 'phone in dead' policy ie don't call in sick!" and another said: "[I] feel that I am judged for taking time off, even when I lost my voice and was unable to consult."
A small number of responses (36 of the 450 vets who commented) mentioned that they did not receive sick pay or only received limited sick pay, so they avoided taking sick leave for financial reasons.
The BVA is reminding all vets that they have a legal right not to attend work when they aren’t well enough do so and that any concerns should be discussed with managers. The free BVA legal helpline is available to members to provide further guidance on taking sick leave.
BVA President Daniella Dos Santos said: "We know that veterinary workplaces are under enormous pressure from staff shortages, and none of us wants to feel like we are letting our colleagues down, but presenteeism only stores up more problems for the future.
"Working when you are ill puts your own health and wellbeing at risk longer term and can also put your colleagues, clients and patients under your care at risk.
"It’s particularly worrying that some of our colleagues feel pressure to work when they feel unwell, especially younger members. As a profession we have made huge steps forward in recognising the issues around mental health and supporting one another and being physically unwell should be the same.
“Anyone who is concerned should speak to their manager and remember that BVA members can always get free advice and support via the BVA legal helpline. Ultimately, it’s important to create a workplace culture that supports the entire veterinary team to prioritise their own physical and mental health."
Photo: Javier Brosch / Shutterstock
BVA president-elect John Blackwell has found himself on the front page of The Times today, and interviewed on Radio 4's Today programme, with a call to end the practice of slitting animal's throats and allowing them to bleed to death in order to produce kosher and halal meat.
According to the newspaper, 600,000 animals are killed this way every week in the UK.
Mr Blackwell is urging Jews and Muslims to allow meat-producing animals to be stunned before they are killed.
Speaking to The Times, Mr Blackwell said: "As veterinary surgeons, it is one of the most important issues on our radar. This is something that can be changed in an instant."
See other media reports here.
Animalcare has announced the launch of Fungiconazol (ketoconazole), the UK's only veterinary licenced antifungal tablet for dogs, indicated for the treatment of ringworm.
Each Fungiconazol tablet contains 200 or 400mg of ketoconazole, to be administered at a dosage of 10mg per kg bodyweight once daily. Each tablet can be split into quarters or halves, allowing accurate treatment for dogs from 5kg (¼ x 200mg tablet daily) to 60kg (1½ x 400mg tablet daily) and beyond. The hypoallergenic chicken flavoured tablets mean that Fungiconazol is also suitable for dogs with food allergies or atopic dermatitis.
Animalcare Product Manager Tony Liepman said "This is a great addition to our antimicrobial range, and shows once again that it’s possible for us to be innovative without breaking anyone's budget. With the supply of the first and only licensed canine antifungal tablet on the market, we have ensured that all veterinary practices have access to Animalcare’s Technical Support department for further advice on treatment or its use in their patients."
Both 200mg and 400mg presentations of Fungiconazol, in 100 tablet blister packs, are now available from wholesalers.
For further information contact Animalcare on 01904 487687, or speak to your regional Animalcare representative (found at www.animalcare.co.uk/contact-us).
Purina carried out a survey earlier this year which revealed the different ways British cat owners manage sensitivity to cat allergens2. They included removing the cat when sensitivities to allergens act up (76%), restricting the cat to specific places in the home (75%), using special cat products on the cat such as dander removers or allergen sprays (64%), bathing the cat (56%) and taking the cat to a groomer (52%).
92% also use a high-quality vacuum cleaner, 66% put covers on their furniture and 26% clean their home and furniture daily to remove traces of cat hair.
Dr Ebenezer Satyaraj, PhD, immunologist for Nestlé Purina Research and lead investigator on the research that led to the development of Pro Plan LiveClear, said: “Many people think that cat hair or dander is the allergen, but it’s actually what’s on it – the major cat allergen called Fel d 1, a protein that cats produce naturally in their saliva.” 3,4
All cats produce Fel d 1, regardless of breed, age, hair length, sex or body weight, but at differing levels.4-6 When cats groom themselves, Fel d 1 gets on the hair and skin through the saliva and with shedding, it eventually gets into the home environment. Feld d 1 attaches itself to any surface it comes into contact with and remains in houses for over a year or more.
Purina says Pro Plan LiveClear contains a specific protein, sourced from eggs, which binds itself to the Fel d 1 and safely neutralises it in the cat’s mouth, thereby reducing the amount of active allergen shed in the environment 7,8.
In a study, feeding Pro Plan LiveClear was shown to reduce the allergens on cat hair and dander by an average of 47%, starting in the third week of daily feeding7.
There have been no studies as yet which have tested the effect of this allergen reduction on human symptoms, but Purina says anecdotal evidence from consumers who have tried the product has been positive thus far.
Amena Warner, Head of Clinical Services at Allergy UK said: "Amena Warner, Head of Clinical Services at Allergy UK said: "There are a number of ways in which cat owners try to manage their exposure to cat allergens and keep their symptoms at bay, including taking antihistamines, using inhalers for quick symptoms relief as sensitivity to cat allergens is often linked to allergy-related asthmas, regularly cleaning and hoovering, bathing and grooming the cat by non-allergic family members. And if these measures do not work, current medical advice is often to relinquish the pet to limit exposure to the allergens.
"Every cat is unique though, and so the level of Fel d 1 they produce varies, just as every person's sensitivity level to these allergens is different. That is why there is no ‘one size fits all’ way to manage exposure to cat allergens. Every little bit helps so a combination of management tools often works best to help reduce cat allergens in your home - the combination is unique to your lifestyle. We welcome the development of Pro Plan LiveClear, which when used as part of a cat allergen management regime, could be a meaningful extra tool for affected households.”
Purina says Pro Plan LiveClear is not intended to replace other cat allergen-reduction strategies but to add another measure that can help reduce the cat allergen burden in cat households.
Pro Plan LiveClear is available at Pets at Home retail stores and from the Purina online shop as a complete life-stage range with six products tailored for Kitten, Adult and Adult 7+.
I had hoped that the increasing absurdity of the reasons given for the rise might have tipped everyone off to the fact that the story was a spoof.
The idea that the College would ask its members to fund some glitzy, showy, award-winning designer headquarters along the lines of London’s City Hall? C’mon. London City Hall employs 1000 staff, whilst the Royal College employs less than 100. And let's face it, the RCVS has no record of having showy offices. On the contrary, it has managed to operate out of a sardine can now for a great many years. Have you ever been in the lift at Horseferry Road? You need to breathe in.
Or that the College had set aside £6M to recruit and pay 20 veterinary surgeons as short term contracted OVs to help in the event of a no-deal Brexit. Let’s say a flight from Delhi to London costs £500, give or take. Twenty vets. That’s £10,000 to get them here. Let's say they’re here for 6 months. That’s £299,500 per vet. You really think the College is going to ask you to pay more than a quarter of a million pounds to fly in a single vet for 6 months? Or that 20 recruits would solve the predicted OV shortage?
Lastly, the quote, supposedly from an Indian vet, but one with a name that doesn’t really sound like a name (still less an Indian one), but does sound strangely like it may be an anagram of April Fool.
There have been a small number of reports of people being really upset by this story. I guess they must have skim read, or only read the headline.
To them I want to say sorry, I genuinely didn’t mean to upset anyone.
In fact, I thought it might cause some reflection on what good value the RCVS really offers. It maintains the register and thereby your ability to practice, it runs the disciplinary process (an essential component of maintaining public trust), it oversees and sets educational standards, it awards Fellowships, Diplomas and Certificates, it runs the Practice Standards Scheme.
All that, and more for £340 per annum?
Honestly? I think it would be cheap at half the price.
Photo: Truth is that the RCVS has operated out of a sardine can for years.By Rl - Own work, CC BY-SA 3.0, Link
Kruuse is to launch a new Manuka honey dressing at BEVA 2011 in September.
Kruuse says that honey has been used as a topical anti-microbial agent and dressing for over 2000 years, and that honey derived from the nectar of the Manuka tree (Leptospermum scoparium) has its own unique chemical properties. Manuka honey contains glucose oxidase imparted by the bees during its collection and storage. This enzyme facilitates low level release of hydrogen peroxide when in the presence of wound exudates and thus supports cellular proliferation and metabolism through an antioxidant effect. The high sugar and low pH content creates a high osmotic potential which gives honey excellent debridement and anti-inflammatory properties.
The company says that one of the biggest difficulties with the use of honey in wound dressings is ensuring that once applied it stays over the wound area. Many attempts to coat dressings have been unsuccessful; often the active honey ingredient is left within the packaging severely reducing the effectiveness of the dressing. Kruuse says its Manuka dressings have the active honey impregnated 'within' the dressing, which ensures precise and easy application even if wearing surgical gloves.
The Kruuse Manuka dressings range comes in impregnated adherent (Kruuse Manuka AD), non-adherent dressing (Kruuse Manuka ND) and 15g tube of Manuka G. Each dressing comes in 3 sizes 5x5 cm , 10x12.5 cm and the KRUUSE Manuka roll (10x100 cm) a unique product ideal for large vertical wounds. E.G. Equine forelimb.
Kruuse also says that the antimicrobial potency in Manuka honey is rated by a standardised rating known as Unique Manuka Factor (UMF). The higher the UMF the better the antimicrobial effect. A minimum UMF of 10 is required to ensure sufficient effect in the wound environment, Kruuse Manuka Honey Wound Dressings have a Unique Manuka Factor of 15.
There is a restricted annual supply of Manuka honey as this unique product supply is controlled by a small number of producers in New Zealand. Many current honey products available use blends of Manuka honey with other poorer quality honey, these are often less effective. Kruuse Manuka uses 100% Manuka honey in all its dressings with the profits of the sale being returned directly to the Maori tribe that oversee the production of Manuka honey.
Andrew Groom, Managing Director Kruuse UK Ltd. said: "I am very excited that we have been able to secure a direct connection to supply this unique product with the knowledge that the Maori suppliers will see the returns for generations to come whilst this new range of dressing will add huge versatility for day to day wound management!"
Lead author Professor Clare Rusbridge, Chief of Neurology at Fitzpartick Referrals, conducted the study because of a lack of clarity on the recognition and diagnosis of the clinical signs associated with CM as opposed to syringomyelia (SM).
CM is an abnormality in the skull, making it smaller, and impacting on the brain to alter the flow of cerebrospinal fluid; this results in pain and a collection of fluid pockets within the spinal cord. These fluid pockets are commonly known as SM and over time can cause irreversible damage to a dog’s spinal cord. However it is not clear whether signs of pain in affected dogs are due to CM or SM or both.
To try to rectify this, Clare studied the medical records of all the cavalier King Charles spaniels diagnosed with CM-associated clinical signs presenting to her at Fitzpatrick Referrals over a five year period. She documented the historical and examination findings and related them to the MRI findings, including presence and size of the SM.
She found common signs in all dogs were vocalisation, spinal pain (neck, middle or lower back), reduced activity, reduced stairs or jumping ability, aversion to being touched or groomed, altered emotional state (described as being more timid, anxious, withdrawn or aggressive) and sleep disturbance.
A tendency to rub or scratch at the head or ears was common but was more likely in dogs with small or no SM suggesting that this may be a sign of head discomfort associated with CM. Head and ear rubbing was not associated with the presence of material within the middle ear (a condition which is also common in this breed and often given the acronym PSOM).
The only signs that were specific to SM were phantom scratching, scoliosis (twisted spine) and weakness and these were only present when the SM was large (at least 4mm wide).
Clare says this study is important because it suggests that CM alone is a cause of pain in many dogs. The aim now is to use the information gained in this study to develop a questionnaire to determine risk of CM and monitor the response to clinical signs.
Reference
Photo: Charlie on a bad day
Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says are specifically targeted to reduce scar tissue formation so horses can return to the intended level of performance, with a reduced risk of re-injury1.
According to the company, a single dose decreases scar tissue formation with consistent and proven results 2.
RenuTend is administered by intralesional injection and complements Boehringer Ingelheim’s other equine stem cell product Arti-Cell Forte, which is authorised to treat mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.
RenuTend will be available in September this year.
In the meantime, Boehringer is encouraging veterinary surgeons to register their interest with their BIAH representative or call 01344746960 in order to get updates or product information as soon as it becomes available.
Sam and Dick will be joint Clinical Directors of the hospital and co-owners of the business alongside the Pets at Home Vet Group, their Shared Venture Partner.
They say the vision is to create a world-class facility with a team of highly motivated veterinary specialists, nurses and support colleagues providing outstanding levels of service to meet the needs of referring veterinary surgeons, their clients and patients.
The purpose-built facility will offer specialist referral services across a range of disciplines, including anaesthesia, diagnostic imaging, internal medicine, orthopaedics, neurology and soft tissue surgery. Emergency referrals will be accepted seven days a week, 24 hours a day.
Sam said: "It is truly exciting to build a new team of experienced specialists who have clinical excellence as their priority. We also relish the chance to develop great relationships with professional colleagues in first opinion practices. This will allow our hospital to deliver an exceptional level of service for referring veterinary surgeons and their patients."
Dick said: “This is a very exciting step and I am delighted to be instrumental in ensuring that our new centre in Scotland offers the very best in veterinary care”.
The hospital will be based at Deer Park in Livingston, with convenient parking and easy access to the M8 and other major road and rail networks. In addition to clinical services, it will provide a CPD programme, including internship and residency opportunities.
The CMA provisional decision was widely seen as less interventional than had been expected, largely demanding transparency over things like pricing, practice ownership and billing, which many practices had already implemented.
However, one provisional decision was that regardless of their status, all veterinary practices should inform owners that they can ask for a written prescription and explain that they may be able to have it fulfilled cheaper online.
Two of the largest online veterinary pharmacies are animed.co.uk, which is owned by CVS, and peddrugsonline, which is owned by IVC.
So in effect, the decision asked independent practices to direct their clients to competitor businesses.
What you might call a bitter pill to swallow.
In the light of the announcement, CVS issued a press release citing the "clarity" afforded by the CMA announcement and the fact that it does not think the CMA's proposed remedies will have a material impact, as factors behind its decision to seek a Main Market listing.
The company has also announced a £20m share buyback programme.
Duncan makes three requests of the UK Government:
The first is to make changes to encourage more overseas vets, and specifically the return of EU vets.
The second is to increase funding for UK universities to provide veterinary courses.
The final request is to update the regulatory framework to enable veterinary nurses to expand their role.
Full article: https://ivcevidensia.co.uk/News/duncan-phillips-time-to-overhaul-vet-support
Baycox Iron Injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.
Professor Nicole Kemper, Director of the Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour at the University of Veterinary Medicine Hannover in Germany said: "Piglets go through intense handling in their first days of life. While this is done to give them a better start to life and protect them from disease, it can also cause a lot of stress. Measures to reduce the need for piglet handling can make an important contribution to enhancing piglet well-being in the farrowing pen."
Octavio Orlovsky Eckhardt, Head of Species Marketing Swine at Animal Health, Bayer said: "A combination therapy that can effectively address these concerns with reduced handling can make a real difference for pig health and well-being.
"At the same time, farmers and workers can benefit from the reduced labour. For example, on a 1,000 sow farm, the reduced complexity is estimated to save up to one full work day every month."
For more information on Baycox Iron Injection, contact your local Bayer Animal Health representative.
The company is making the claim based on a £20,000 study it conducted with three dermatology specialists from three different clinics, in different parts of the country.
Trevor Hardcastle, Vet-AI’s chief data scientist said: "We have undertaken a small-scale trial of remote diagnosis of dermatology conditions by veterinary dermatology specialists in canine patients, which has resulted in almost perfect agreement. No significant evidence was found that veterinary dermatology specialists are measurably compromised in their ability to accurately diagnose common dermatology conditions by being remote from the patient."
Strangely, given the strength of the claim, its importance and Vet AI's obvious vested interest in the result, there was no other information contained within the company's press release. No mention of who the specialists were, nothing about the study design, and nothing about the basis on which the claim is made.
However, presuming the company meant Specialists not specialists, it would be very unusual if they had agreed for an announcement of this importance to be made without the evidence being reasonably robust. So it's probably worth suspending judgement until the study is published in full.
Meantime, the company also says its own research into online diagnosis amongst pet owners has shown that more than 50% of people have avoided taking their pets to the vet for cost reasons, yet more than 65% have tried online self-diagnosis. Again, Vet AI doesn't reveal how many pet owners were asked, or how they were sampled.
Vet-AI co-founder Sarah Warren said: "Things like dermatological issues are beautifully aligned to remote consultation because they’re visual so we can gain a wealth of information from images and distribution maps and easily recommend treatments.
"This needs to happen in a regulated, ethical and correct way with a view to improving animal welfare.
"The RCVS has a chance to ensure that people have access to quality vet help online in an effective way. They can do this, or they can allow them to continue accessing poor-quality advice. As a profession, it’s vital we respond to the needs of pet owners."
AB Science, a young Paris-based biotech company, has announced the pan-European commercial launch of its veterinary anticancer drug, Masivet
Masivet was approved in November 2008 by the European Medicines Agency (EMEA) for the treatment of dogs with non-resectable grade 2 or 3 mast cell tumours. Masivet's active pharmaceutical ingredient is masitinib, a tyrosine kinase inhibitor. Masitinib, discovered and developed by AB Science, belongs to a therapeutic class of drug known as targeted therapy that is, according to AB Science, revolutionising the treatment of cancer in humans.
Alain Moussy, CEO of AB Science said: "Masivet is the first product ever registered as a cancer treatment in veterinary medicine. AB Science is a dynamic and very entrepreneurial biotech company, and is proud to have introduced a drug that can extend the life of dogs suffering from cancer ahead of the large pharmaceutical companies".
The company says Mastocytoma can be an aggressive cancer with a poor prognosis, and represents up to 20% of all cutaneous canine tumours. Some breeds are particularly susceptible, among them Golden Retrievers, Labradors and Boxers. Cancers have the same prevalence in dogs as in humans (1 dog in 4 will suffer from cancer during its lifetime) but surprisingly, no drugs developed for veterinary medicine with a demonstrated efficacy and safety have ever been approved until the arrival of Masivet.
The company claims two main benefits of the new treatment:
AB Science is a biotech company specialising in developing targeted drugs for high need indications, such as cancers, chronic inflammatory diseases and neurodegenerative disorders. Masitinib is the most advanced drug in the pipeline. Now being marketed in veterinary medicine, masitinib is also under development in humans, with phase 3 clinical studies in pancreatic cancer and in gastrointestinal stromal tumour (GIST).
Alain Moussy said: "This registration in veterinary medicine is good news for the future success of masitinib in humans, for whom we are aggressively developing it in cancers and other indications with high morbidity or pain.
"It is very unusual to develop such an innovative product simultaneously in veterinary and human medicines, and even more so that the product is registered in veterinary medicine first. There is no doubt that experts in human oncology will be watching Masivet's future very closely from now on.. However, people will have to wait a while before benefiting from masitinib because it is unlikely to be available to man before 2012".
For more information, see www.masivet.com and www.ab-science.com
The guidelines, launched during WSAVA World Congress 2018 in Singapore, aim to bridge differing perceptions of welfare around the world and help veterinary surgeons and nurses tackle the ethical questions and moral issues which impact welfare.
They also offer guidance to ensure that, in addition to providing physical health advice and therapy to their patients, veterinary surgeons and nurses can advocate for their psychological, social and environmental wellbeing.
Dr Shane Ryan, incoming President of the WSAVA and former Chair of the WSAVA Animal Wellness and Welfare Committee, said: "As veterinarians, our responsibility extends far beyond the physical health of our patients. Animal welfare as a science is a new and rapidly developing discipline and veterinarians need current, evidence-based invformation to enable them to maintain the highest welfare standards and to provide knowledgeable, accurate advice for pet owners and communities.
"Our new Guidelines provide recommendations, checklists and other tools to promote optimal levels of welfare throughout the veterinary visit. They also offer guidance on increasing welfare beyond the doors of the clinic through outreach activities.
"As levels of pet ownership increase in many regions of the world, including Asia, it is essential that veterinarians champion animal welfare and the WSAVA hopes that these new Guidelines will encourage our members to adopt best practice and set the highest standards.
"I would like to thank the members of the Animal Welfare Guidelines team, who worked so hard to create them and, of course, our sponsor, Waltham, whose constant support was instrumental in enabling us to deliver them."
The Animal Welfare Global Guidelines for Companion Animal Practitioners and the Veterinary Team are available for free download at: https://bit.ly/2D3RAoc.
A graduate of University College Dublin, Richard started out in first opinion practice after completing an internship at the University of Glasgow.
While studying medicine, Richard researched mast cell tumours in dogs, which led to an MSc in clinical Oncology. He went on to complete a PhD on mast cell tumours at the Royal Veterinary College in 2008.
Richard works with referral oncology patients and clients two days a week at LVS and currently spends the rest of his working week as an oncology consultant for IDEXX Laboratories.
From February, Richard will also be working at Southfield Veterinary Specialists in Laindon, Essex, thereby allowing him to refer oncology patients for radiation therapy at Southfields when necessary.
Richard said: "Having never been comfortable with operating myself, working with a team of this calibre and experience in a welcoming environment within central London was very attractive. It has been a very fulfilling role for me, especially as both our team and the scope of the services we can offer continue to expand.
"Given the high standard of care offered by local vets in the area, the patients referred to LVS are often very challenging. Together with our clients’ high expectations, the service is definitely not run-of-the-mill but all the more rewarding because of that.
"I’m looking forward to bringing my experience in both research and clinical spheres to LVS."
Richard’s main professional interests are mast cell tumours, novel diagnostics and immunotherapeutics, but he is experienced in all aspects of veterinary oncology and can also offer advice about internal medicine cases.